Skip to content

Medexus Pharmaceuticals Inc Sustainability Reports

Medexus Pharmaceuticals Inc. operates as a specialty pharmaceutical company focused on the licensing, development, and commercialization of innovative and rare disease treatment solutions. Its product portfolio spans therapeutic areas such as hematology, hemato-oncology, rheumatology, and allergy within the North American market.

Sector: Manufacturing

Country: Canada

Exchange: Toronto Stock Exchange

LEI: 8945002TBEYY0HLH1M19

FIGI: BBG0029BPRG7

12 reports from 2021 to 2026